Business enquiries

We'll email you back within 24 hours.

Get in touch

General enquiries

For member enquiries, public data requests, or general questions.

Contact usor visit Member helpdesk

Members

Take surveys and earn points as a member of the YouGov panel.

Sign inRegister as a member

Business

Access YouGov products and services as a business.

Sign inRegister as a client
Search icon
Do you support or oppose weight loss drugs, such as Mounjaro and Ozempic, being available on the NHS for people who are obese? Published on 1 April 2026 → Survey conducted on 1 April 2026 on 4225 GB adults
14%
38%
20%
15%
13%
By:
14%
38%
20%
15%
13%
Related topics

Published on the same day

Which of the following comes closest to your understanding of April Fools' Day pranks?

See results

And do you support or oppose weight loss drugs, such as Mounjaro and Ozempic, being available on the NHS for people who are overweight but not obese?

See results

Explore more opinion data

Thinking about the availability of weight loss drugs such as Mounjaro and Ozempic from doctors, do you believe they are too easily available, not available enough, or do you think the current balance is about right?

Updated on 24/02/2026
40%
28%
17%
Survey / 6607 adults per wave

Weight loss drugs in Britain: How they’re changing grocery spending, takeaway consumption and food choices

Article

How easy or difficult do you find coping with a common cold i.e. being able to do all the things you would usually do as effectively as you would usually do them?

Updated on 06/02/2026
55%
23%
13%
Survey / 7176 adults per wave

And do you think men or women in general are better at coping with a common cold?

Updated on 06/02/2026
32%
29%
26%
Survey / 7176 adults per wave

Factors influencing Brits in the choice of food they eat

Tracker

How healthy Brits say their eating habits are

Tracker

YouGov News Tracker: 29 - 30 March 2026

Article

Few Britons believe any party sees cost of living as a top priority

Article

Voting intention, 29-30 March 2026: Ref 23%, Grn 19%, Con 19%, Lab 18%, LD 12%

Article